GoHealth, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating Activities
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Share-based compensation
Depreciation and amortization
Amortization of intangible assets
Amortization of debt discount and issuance costs
Gain on bargain purchase
Loss on extinguishment of debt
Loss on sublease
Deferred tax liability
Non-cash lease expense
Other non-cash items, net
Operating lease impairment charges
Change in fair value of contingent consideration
Goodwill impairment charges
Intangible asset impairment charges
Non-cash restructuring charges
Accrued interest payable in kind
Indefinite and long-lived asset impairment charges
Changes in assets and liabilities:
Accounts receivable
Commissions receivable
Prepaid expenses and other assets
Accounts payable
Accrued liabilities
Deferred revenue
Commissions payable
Operating lease liabilities
Other liabilities

Net cash provided by (used in) operating activities
Investing Activities
Acquisition of business, net of cash
Acquisition of business, net
Purchases of property, equipment and software
Net cash (used in) provided by investing activities

Financing Activities
Proceeds from borrowings
Call premium paid for debt extinguishment
Distributions to non-controlling interests
Advancement to NVX Holdings, Inc.
Repayment of borrowings
Payment of debt discount and issuance costs
Repurchase of shares to satisfy employee tax withholding obligations
Proceeds from stock option exercises
Proceeds from sale of Series A redeemable convertible preferred stock
Issuance cost payments from issuance of Series A redeemable convertible preferred stock
Payment of preferred stock dividends
Principal payments under capital lease obligations
Proceeds from issuance of Class A common stock sold in initial public offering, net of offering costs
Payment of partial consideration to Blocker Shareholders in the Blocker Merger
Proceeds received upon issuance of preferred units
Proceeds received upon issuance of common units
Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash and cash equivalents
Increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental Disclosure of Cash Flow Information
Interest paid
Income taxes paid
Non-cash investing and financing activities:
Issuance of equity to settle contingent consideration liability
Net issuance of Class A and Class B common stock in connection with the Transactions
Settlement of contingent consideration liability
Purchases of property, equipment and software included in accounts payable
Purchases of property, equipment and software under capital leases

Comments